Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00197678 · ClinicalTrials.gov registry record · Phase 3
Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women
A Phase 3 study, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- Phase 3
- Development phase
- 1,141
- Enrollment target
NCT00197678: Completed Phase 3 study, sponsored by Harvard School of Public Health (HSPH).
NCT00197678 is a Phase 3 study that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 1,141 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00197678, a Phase 3 study, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,141 participants
- Enrollment target
Study Summary
The purpose of this study is to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV positive women decreases the risks of low birth weight (\<2500 g), and pre-term birth (\< 37 weeks gestation), compared to multivitamin supplements at doses above the RDA.
Interventions
- DIETARY_SUPPLEMENT Multivitamins-Multiples of RDA
- DIETARY_SUPPLEMENT Multivitamins-Single RDA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,141 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-07 |
| Phase | Phase 3 |
What the finished NCT00197678 record still lists
NCT00197678 is an interventional study that assigns participants to a tested intervention. Its 1,141 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% higher).
The record links to 0 conditions, and to 2 interventions - of which Multivitamins-Multiples of RDA is the first listed.
NCT00197678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00197678 about?
NCT00197678 is a clinical study titled "Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women". The purpose of this study is to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV positive women decreases the risks of low birth weight (\<2500 g), and pre-term birth (\< 37 weeks gestation), compa...
What is the current status of trial NCT00197678?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,141 participants. The study started on 2002-11. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00197678?
The interventions under investigation include: Multivitamins-Multiples of RDA (DIETARY_SUPPLEMENT), Multivitamins-Single RDA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00197678?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00197678's enrollment target sits among peer trials
1,141 243rd of 2000 higher than 1,758 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia